期刊文献+

左心室射血分数正常心衰的治疗策略 被引量:2

Progress on management of heart failure with preserved ejection fraction
下载PDF
导出
摘要 左心室射血分数正常心衰(HFpEF)目前已经成为心衰的主要类型,而且呈不断增加趋势,已引起临床广泛关注。本文简要叙述了HFpEF的流行病学、病理生理学特点,重点评述了急慢性HFpEF的治疗进展,以供基础与临床深入研究参考与借鉴。 More than half of heart failure have a normal fraction(HFpEF)and represents a major challenge in cardiovascular medicine,from which clinical interests emerged.In this review,we briefly outlined the epidemiology,pathophysiology of HFpEF and focused on the management of it in both acute and chronic situation.
作者 刘永铭
出处 《西部医学》 2015年第3期323-326,共4页 Medical Journal of West China
基金 国家临床重点学科建设项目(2013 老年病学)
关键词 心衰 左心室射血分数正常心衰 治疗 Heart failure HFpEF Management
  • 相关文献

参考文献28

  • 1Owan TE, Hodge DO, Herges RM, etal. Trends in prevalence and outcome of heart failure with preserved ejection fraction[J]. N Engl J Med, 2006, 355(3):251-259.
  • 2Bhatia RS, Tu JV, Lee DS, etal. Outcome of heart failure with preserved ejection fraction in a population-based study[J]. N Engl J Med, 2006, 355(3) :260-269.
  • 3Borlaug BA, Paulus WJ. Heart failure with preserved ejectionfraction: pathophysiology, diagnosis, and treatment[J]. Euro- pean Heart Journal,2011,32, 670-679.
  • 4Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presenta- tion, management, and in-hospital outcomes of patients admit- ted with Acute Decompensated Heart Failure with preserved systolic function[J]. J Am Coil Cardiol, 2006, 47(1):76-84.
  • 5Fonarow GC, Stough WG, Abraham WT, et al. Characteris- tics, treatments, and outcomes of patients with preserved sys tolie function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry[J].J Am Coll Cardiol, 2007, 50(8) : 768-777.
  • 6Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in de- compensated heart failure with cardiorenal syndrome[J]. N Engl J Med, 2012, 367(24):2296-2304.
  • 7Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the A- merican College of Cardiology Foundation/American Heart As- sociation Task Force on Practice Guidelines [J]. Circulation, 2013,128 : e240-e327.
  • 8Schwartzenberg S, Redfield MM, From AM, et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction[J]. JAC Elsevier Inc, 2012,59(5):442-451.
  • 9Metra M, Cotter G, Davison BA, et al. Effect of serelaxin on cardi- ac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Fail- ure (RELAX-AHF) development program: correlation with out- comes{J]. J Am CoIl Cardiol, 2013, 61(2):196-206.
  • 10O'Connor CM, Starling RC, Hernandez AF, et al. Effect of ne- siritide in patients with acute deeompensated heart failure[J].N Engl J Med, 2011,365(1) :32-43.

同被引文献16

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部